Sphingosine‐1‐phosphate receptor 1 mediates elevated IL‐6 signaling to promote chronic inflammation and multitissue damage in sickle cell disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sphingosine‐1‐phosphate receptor 1 mediates elevated IL‐6 signaling to promote chronic inflammation and multitissue damage in sickle cell disease

Published:2018-01-17 Issue:5 Volume:32 Page:2855-2865
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Zhao Shushan¹,Adebiyi Morayo G.²,Zhang Yujin²,Couturier Jacob P.³,Fan Xuegong¹,Zhang Hongqi¹,Kellems Rodney E.²,Lewis Dorothy E.³,Xia Yang⁴²⁵

Affiliation:

1. Department of Orthopedics Central South University Changsha China

2. Department of Biochemistry and Molecular Biology The University of Texas at Houston Medical School The University of Texas Houston Texas USA

3. Department of Internal Medicine The University of Texas at Houston Medical School The University of Texas Houston Texas USA

4. Department of Nephrology Xiangya Hospital Central South University Changsha China

5. M. D. Anderson–University of Texas Health Graduate School (UTHealth) Houston Texas USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.201600788RR

Reference41 articles.

1. Sphingosine-1-phosphate signaling and its role in disease

2. Sphingosine 1-Phosphate-induced Cell Proliferation, Survival, and Related Signaling Events Mediated by G Protein-coupled Receptors Edg3 and Edg5

3. Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement

4. Sphingosine 1-Phosphate Induces Angiogenesis: Its Angiogenic Action and Signaling Mechanism in Human Umbilical Vein Endothelial Cells

5. Sphingosine-1-Phosphate Links Persistent STAT3 Activation, Chronic Intestinal Inflammation, and Development of Colitis-Associated Cancer

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating Lipidomics, Metabolomics, and Network Pharmacology to Reveal the Mechanism of Cannabidiol against Inflammation in High-Fat, High-Cholesterol Diet-Induced Mice;Journal of Agricultural and Food Chemistry;2024-08-16

2. Structural elucidation and immunomodulatory activities in vitro of type I and II arabinogalactans from different origins of Astragalus membranaceus;Carbohydrate Polymers;2024-06

3. S1PR3/RhoA signaling pathway in microglia mediates inflammatory activation in early brain injury after subarachnoid hemorrhage;2024-05-15

4. Signaling controversy and future therapeutical perspectives of targeting sphingolipid network in cancer immune editing and resistance to tumor necrosis factor-α immunotherapy;Cell Communication and Signaling;2024-05-02

5. Dysregulation of sphingolipid metabolism in pain;Frontiers in Pharmacology;2024-03-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3